Treatment Pathway

Treatment of Gout

Gout is a form of inflammatory arthritis caused by elevated uric acid levels (hyperuricemia) that form crystals in joints. It causes sudden, severe attacks of pain, swelling, redness, and tenderness, most often in the big toe.

ADA (American Diabetes Association)AACEESE (European Society of Endocrinology)ETA (European Thyroid Association)NICE

Symptoms Causes Treatment When to See a Doctor Related Questions

Managing Gout effectively requires a combination of medical treatment, lifestyle modification, and regular monitoring. With a structured management plan, most people with Gout can maintain a good quality of life and prevent serious complications.

First-Line Treatment Principles

✓Individualise glycaemic targets based on patient age, comorbidities, and hypoglycaemia risk
✓Metformin remains first-line for type 2 diabetes (unless contraindicated)
✓SGLT2 inhibitors and GLP-1 RAs for patients with established CV disease, HF, or CKD
✓Insulin when oral agents insufficient (T2DM) or as primary therapy (T1DM)
✓Thyroid hormone replacement (levothyroxine) is the standard of care for hypothyroidism

What to Do Now

Learn your personal risk factors for Gout (family history, age, lifestyle)
Attend regular health check-ups and screening tests appropriate for your age and risk
Track new or changing symptoms, especially those associated with Gout
Use our AI symptom checker to assess whether your symptoms fit an early Gout pattern
Discuss preventive strategies and early monitoring with your GP
Build a personalised management plan with your GP or specialist
Adhere consistently to prescribed medications — do not stop without medical advice
Adopt a Gout-appropriate diet (anti-inflammatory, low-glycaemic, or disease-specific)

Medications Used in Gout

AllopurinolXanthine Oxidase Inhibitor

Allopurinol is a xanthine oxidase inhibitor that lowers uric acid levels to prevent gout attacks and uric acid kidney stones.

FebuxostatXanthine Oxidase Inhibitor

Febuxostat is a xanthine oxidase inhibitor that lowers uric acid levels to prevent gout attacks and uric acid kidney stones.

ColchicineAntigout Agent

Colchicine is used to treat or prevent acute gout attacks by reducing inflammation or increasing uric acid excretion.

ProbenecidAntigout Agent

Probenecid is used to treat or prevent acute gout attacks by reducing inflammation or increasing uric acid excretion.

BenzbromaroneAntigout Agent

Benzbromarone is used to treat or prevent acute gout attacks by reducing inflammation or increasing uric acid excretion.

Non-Pharmacological Management

•Medical nutrition therapy: calorie-controlled, low-glycaemic-index diet; carbohydrate counting for insulin users
•Structured physical activity: 150 min/week aerobic + resistance training 2×/week
•Weight loss: 5–10% body weight reduces HbA1c by 0.5–2% and improves insulin sensitivity
•Smoking cessation: accelerates diabetes complications (retinopathy, nephropathy)
•Alcohol restriction: masking of hypoglycaemia; contributes to metabolic dysfunction
•Sleep optimisation: poor sleep worsens insulin resistance and metabolic control
•Self-monitoring of blood glucose (SMBG) or continuous glucose monitoring (CGM)

Treatment Goals

🎯HbA1c target: <7% (53 mmol/mol) in most non-pregnant adults; individualised in elderly

🎯Prevention of microvascular complications: retinopathy, nephropathy, neuropathy

🎯CV risk reduction: BP, lipid, and glucose targets

🎯Weight management and metabolic improvement

🎯Euthyroid state in thyroid disorders (TSH in normal range)

Monitoring Parameters

◆HbA1c: every 3 months until stable, then every 6 months (target <7% in most T2DM)
◆Fasting glucose and CGM metrics (time in range >70% for most)
◆Blood pressure: target <130/80 mmHg in diabetes
◆Lipid panel: annually; intensify if LDL >2.5 mmol/L or established ASCVD
◆Renal function (eGFR, urine albumin-creatinine ratio): annually
◆Eye examination (retinal screening): annually
◆Foot examination: at every visit; annual podiatry review
◆TSH monitoring: 6-weekly after levothyroxine initiation, then annually when stable

Red Flags — When to Escalate

⚠Any of the characteristic symptoms of Gout — even mild — in a high-risk individual
⚠Progressive worsening of early warning signs over weeks
⚠Laboratory abnormalities (e.g., blood sugar, inflammatory markers) without full symptoms
⚠Unexplained weight loss, night sweats, or fatigue persisting >2 weeks
⚠Strong family history of Gout combined with new relevant symptoms
⚠Sudden worsening of Gout symptoms despite established treatment

Escalation Criteria

→HbA1c persistently >10% despite maximal oral therapy → insulin initiation
→Diabetic ketoacidosis (DKA) or hyperosmolar hyperglycaemic state (HHS): emergency hospitalisation
→Severe hypoglycaemia (glucose <3 mmol/L with confusion/loss of consciousness): glucagon, IV dextrose
→New or worsening nephropathy (eGFR <30): nephrology review; restriction of nephrotoxic agents
→Thyroid storm or myxoedema coma: intensive care emergency

Special Populations

Elderly: relax HbA1c targets to 7.5–8% to reduce hypoglycaemia risk; avoid SUs and long-acting insulin

Pregnancy: tight glycaemic control (HbA1c <6.5%); insulin preferred; avoid oral hypoglycaemics in T1DM

CKD: metformin contraindicated if eGFR <30; SGLT2i adjust dose; dose-reduce insulin

Frailty: individualise therapy; avoid polypharmacy and hypoglycaemia-prone regimens

Clinical Insights

Differential Diagnosis

Conditions that mimic Gout — key distinguishing features & tests

Evidence & Guidelines

Clinical trials, guideline strength, and treatment recommendations

Compare With Similar Conditions

Gout vs Reactive Arthritis

4 shared symptoms · treatment pathway differences

→

Gout vs Psoriatic Arthritis

3 shared symptoms · treatment pathway differences

→

Not sure about your symptoms?

Our AI Symptom Checker analyses your symptoms and suggests the most likely diagnoses — including relevant treatment pathways.

Use AI Symptom Checker →